Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aerie Pharmaceuticals Inc.

www.aeriepharma.com

Latest From Aerie Pharmaceuticals Inc.

ViiV Wins Fast-Track Review At EMA For HIV Therapy

A number of new products have been submitted for review at the European Medicines Agency. While marketing authorization applications from ViiV Healthcare and BioMarin Pharmaceutical are being fast-tracked, a submission from Incyte is not.

Europe Approvals

New EU Approvals

The Pink Sheet’s list of EU centralized approvals of new active substances has been updated with two new products including Merck Sharp & Dohme's Ebola vaccine, Ervebo. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).

Approvals Europe

EMA OKs Seven New Drugs But Delivers Another Blow To Emmaus

Seven new drugs have this week moved closer to gaining EU approval following positive recommendations from the European Medicines Agency, but Emmaus’ glutamine product has fared less well and the company is considering another route for getting the drug to sickle cell disease patients in Europe

Europe Drug Review

Orphan AML Products Face CHMP Questioning

Companies developing new AML treatments are among those being called before the European Medicines Agency this week for questioning over marketing applications approaching the end of the review process. 

Europe Drug Review
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aerie Pharmaceuticals Inc.
  • Senior Management
  • Vincente, Jr. Anido, PhD , Chmn. & CEO
    Richard J Rubino, CFO
    Casey C Kopczynski, PhD, CSO
    Gary Menichini, US Chief Commercial Officer
    Richard Lewis, MD, CMO
    Eric Carlson, PhD, VP, R&D
    Craig Skenes, VP, Bus. Dev.
    David A Hollander, MD, Chief R&D Officer
    Michelle Senchyna, PhD, VP, Clinical Dev. & Medical Affairs
  • Contact Info
  • Aerie Pharmaceuticals Inc.
    Phone: (919) 237-5300
    4301 Emperor Blvd., Ste. 400
    Durham, NC 27703
    USA
UsernamePublicRestriction

Register